ACR and PCR urine tests: what they measure and what your result means

Patients often arrive in clinic with urine test results they do not fully understand. The ACR and PCR tests are central to assessing kidney health, and getting comfortable with what they mean helps patients engage with their care. This article walks through what I explain to patients about these tests.

If you have had your kidneys checked, you have probably come across two different urine tests: ACR and PCR. They sound similar, both measure protein in urine, and both can be done on a single random urine sample. But they measure slightly different things, and they are used in slightly different contexts. Understanding the difference helps you make sense of your results and understand what your doctor is monitoring.

This guide walks through what ACR and PCR are, how they are measured, what the numbers mean, what causes protein in urine, and how the results guide treatment.

ACR stands for albumin-to-creatinine ratio. It measures the amount of albumin in the urine relative to the amount of creatinine. Albumin is the main protein found in blood plasma. Healthy kidneys allow only tiny amounts of albumin to pass into the urine. When the filtering apparatus of the kidney is damaged, larger amounts leak through. The ACR is sensitive to small amounts of albumin and is the standard test for screening for kidney disease in patients with diabetes, hypertension, and chronic kidney disease.

PCR stands for protein-to-creatinine ratio. It measures the total protein in urine relative to creatinine. This includes albumin but also other proteins that may be present in larger amounts in some kidney conditions. The PCR is less sensitive to small amounts of albumin than the ACR but better captures situations where many different proteins are being lost (such as in nephrotic syndrome or in tubular kidney diseases).

Why creatinine? Both tests use creatinine as the reference because urinary creatinine excretion is relatively constant from hour to hour and from day to day in a given individual. By measuring the ratio of albumin or protein to creatinine, the tests effectively correct for urine concentration. This means a single random urine sample (preferably a morning specimen, but any time of day works) can give a result equivalent to a 24-hour urine collection. The 24-hour urine collection, traditionally used to measure proteinuria, is now rarely needed because the ratio measurements give equivalent information without the inconvenience.

In most clinical situations, ACR and PCR give similar information. The ACR is generally preferred for screening and routine monitoring because of its sensitivity to small amounts of albumin, which is the earliest sign of kidney damage in many conditions. The PCR is sometimes preferred for monitoring very heavy proteinuria, when albumin alone may not give the full picture, or for certain glomerular diseases.

Results are interpreted as follows.

For ACR, the categories are based on KDIGO guidelines. An ACR below 3 mg/mmol is normal. ACR of 3 to 30 is moderately increased (sometimes called microalbuminuria in older literature). ACR above 30 is significantly increased (sometimes called macroalbuminuria). Within the elevated range, the higher the number, the higher the risk of progression and the stronger the indication for treatment.

For PCR, an PCR below 15 mg/mmol is generally normal. PCR of 15 to 50 is moderately increased. PCR above 50 is significantly increased. PCR above 220 mg/mmol is nephrotic-range proteinuria and warrants urgent specialist evaluation.

A single elevated result should be confirmed with one or two repeat tests before being acted on. Transient causes of elevated ACR or PCR include urinary tract infection, fever, vigorous exercise, dehydration, and (in women) menstruation. Persistent elevation across multiple tests over weeks is the clinically meaningful finding.

What causes elevated ACR or PCR? The list of causes is long but the main ones are well established. Diabetes is the most common cause of elevated ACR in adults. Around 30 to 40 per cent of patients with type 2 diabetes will eventually develop some degree of albuminuria. Hypertension contributes to many cases, both alone and in combination with other conditions. Glomerular diseases including IgA nephropathy, membranous nephropathy, focal segmental glomerulosclerosis, lupus nephritis, and others all cause varying degrees of proteinuria. Chronic kidney disease of any cause is associated with proteinuria in many patients. Heart failure can cause proteinuria through several mechanisms. Pre-eclampsia in pregnancy causes proteinuria as a defining feature. Multiple myeloma and other plasma cell disorders can cause specific forms of proteinuria that are not always captured well by albumin measurement alone. Certain medications can affect proteinuria.

Why does proteinuria matter? Several reasons. First, it is a marker of kidney damage. The kidneys are not supposed to leak protein. When they do, it indicates that the filtering apparatus has been damaged in some way. Second, it is a predictor of future risk. Higher levels of proteinuria predict faster decline in kidney function and higher cardiovascular risk. Third, it is itself a driver of further damage. Protein in the urine causes inflammation and scarring in the kidney tubules, which contributes to ongoing damage over years. Fourth, it is a treatment target. Reducing proteinuria with medications such as ACE inhibitors, ARBs, and SGLT2 inhibitors translates into slower kidney decline and lower cardiovascular risk.

How are ACR and PCR used to guide treatment? The level determines the intensity of intervention.

For patients with normal ACR or PCR, no specific kidney-directed treatment is needed. Routine attention to general cardiovascular risk factors is appropriate.

For patients with moderately increased ACR (3 to 30), the priorities are tight blood pressure control (target below 130/80), use of an ACE inhibitor or ARB if not already prescribed, optimisation of glucose control in diabetes, and lifestyle measures including reduced salt, weight management, and regular exercise. Monitoring is typically every 6 to 12 months.

For patients with significantly increased ACR (above 30), the same measures apply but with increased intensity. Addition of an SGLT2 inhibitor is recommended for most patients with proteinuric kidney disease, regardless of diabetes status. For patients with diabetic kidney disease and ongoing proteinuria, finerenone may be added. Monitoring is typically every 3 to 6 months.

For patients with nephrotic-range proteinuria (PCR above 220, equivalent to around 3.5 grams of protein in urine per day), specialist nephrology assessment is urgent. A kidney biopsy is often needed to establish the underlying cause, and specific treatment depends on what is found. The conditions to consider include various forms of glomerulonephritis, diabetic nephropathy, and rare causes such as amyloidosis.

Monitoring proteinuria over time provides important information. A rising ACR over months despite treatment usually warrants intensification of therapy. A falling ACR with treatment indicates that the intervention is working. Stability over time at a given level can be acceptable, particularly at moderate levels.

For patients, understanding your ACR or PCR result is one of the most useful things you can do for your kidney health. Asking your GP for the number, tracking it over time, and understanding what it means in your particular situation help you to engage actively with your care. The ACR is a particularly useful test because it picks up early kidney damage long before any change in eGFR, blood pressure, or symptoms. Acting early on persistently elevated ACR pays off substantially over years.

I see private patients at Blackrock Clinic, The Beacon Hospital, Bon Secours Dublin, the Hermitage Medical Centre, and St Vincent’s Private Hospital. If you would like a consultation about your kidney health, you or your GP can contact my secretary through drrorymcquillan.ie. Most patients are seen within two to three weeks of referral.